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lesions and squamous cell carcinomas of the oral cavity. However, no
mutations were detected during oral cancer progression.
doi:10.1016/j.oos.2009.06.579
P3.54. Modulated aberrant expression of Aurora A by osteopontin
is associated with poor prognosis in oral cavity squamous cell
carcinoma
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Introduction: The explosion of microarray studies has promised
to shed light on the identiﬁcation of disease markers. To ﬁnd novel,
undeﬁned prognostic factors, we used the expression proﬁle of poor
prognostic factor of OCSCC, osteopontin, a secreted protein, as a tem-
plate to search for and compare transcriptome expression proﬁles in
a OCSCC microarray database.
Methods: The semiquantitative RT-PCR, western blot, and IHC
approaches were used to evaluate the RNA and protein expression
of Aurora A in paired OCSCC patients’ specimens. Immunohisto-
chemistry analysis of Aurora A expression was assessed in 256
OCSCC patients who underwent tumor resection between 1996
and August 2005 without previous radiotherapy. Results were corre-
lated with clinicopathologic characteristics using univariate and
multivariate analyses. The correlation between OPN and Aurora A
was also assessed in OCSCC specimens. The Aurora A expression le-
vel was explored in human oral cancer cell lines by OPN stimulating.
Results: Among these syn-expression candidate targets, Aurora A
(STK6/STK15) is identiﬁed as one of the correlated genes (Pearson’s
correlation coefﬁcient = 0.62, p = 0.001). Here, we showed that the
mRNA and protein levels of Aurora A were signiﬁcantly overexpres-
sed in OCSCC compared to adjacent non-cancerous tissues and nor-
mal oral mucosa by semiquantitative RT-PCR, western blot and IHC.
The cumulative 5-year survival rate was signiﬁcantly correlated with
a relatively advanced tumor stage, positive nodal status, TNM stage,
and strong expression of Aurora A. Thus, elevated Aurora A expres-
sion is an indicator of poor survival. From semiquantitative RT-
PCR, western blot and IHC staining data, OPN and Aurora A exhibit
highly positive correlations in OCSCC specimens. Moreover, stimula-
tion of oral cancer cells with OPN results in an increase in Aurora A
protein expression.
Discussion: These ﬁnding suggest that Aurora A are not only an
important prognostic factor but also a new therapeutic target in
the OPN/Aurora A pathway for OCSCC treatment.
doi:10.1016/j.oos.2009.06.580
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Oral cancer is considered a multifactorial disease where multiple
exposures interact with the individual genetic background resulting
in risk modulation. Genetic polymorphisms of carcinogen-metabo-
lizing enzyme genes have been associated with the risk of oral
cancer.
This study was done to investigate the role of single nucleotide
polymorphisms (SNPs) within genes of phase I (CYP1A1) and phase
II of the xenobiotic metabolism (GSTM1, GSTT1, GSTP1) and its asso-
ciation with oral cancer risk.
An unmatched case–control study was conducted using 207
newly diagnosed oral cancer patients and 116 non-cancer subjects
selected from the OCRCC database. Peripheral blood was obtained
from consented individuals and the CYP1A1, GSTM1, GSTT1 and
GSTP1 genotypes were determined using polymerase chain reaction
(PCR) and restriction enzyme digestion (RFLP). Simple and multiple
logistic regression yielding odds ratio (OR and aOR) were employed
to measure the association between genetic polymorphisms and risk
of oral cancer.
In comparing cases and controls for CYP1A1 polymorphism, the
OR was 0.843 (95% CI 0.534–1.330) while the OR for GSTM1 null
genotype relative to GSTM1 non-null was 0.987 (95% CI 0.627–
1.554). The OR for GSTT1 null genotype was 0.866 (95% CI 0.541–
1.388) relative to GSTT1 non-null genotype. The OR for GSTP1 poly-
morphism genotype, as compared to the wild-type genotype, was
0.680 (95% CI 0.397–1.164). Although all OR values of CYP1A1 and
GSTs polymorphisms indicated reduced risk against oral cancer risk,
neither CYP1A1, GSTM1 or GSTT1 null nor GSTP1 polymorphisms
genotype was revealed as signiﬁcantly associated with oral cancer
risk.
Analysis showed a lack of evidence to support the association
between the genetic polymorphisms of CYP1A1, GSTM1, GSTT1
and GSTP1 and risk of oral cancer.
doi:10.1016/j.oos.2009.06.581
P3.56. CYP1A1, GSTM1 and GSTT1 polymorphisms and oral cancer
– Correlation with patients’ status at 2-year, age of onset, nodal
status, tumor size and stage
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Altered expression of xenobiotic enzymes such as CYP1A1,
GSTM1 and GSTT1 has been reported in some malignant tumors
including oral cancer. However, the correlation between these
enzymes and clinicopathologic parameters has not been well docu-
mented. The aim of this study was to investigate the associations
between CYP1A1, GSTM1 and GSTT1 polymorphisms with patients’
status at 2-year, age of onset, nodal status, tumor size and disease
stage. A total of 195 oral cancer patients were included in this study.
Peripheral blood was obtained from consented individuals and
CYP1A1, GSTM1 and GSTT1 genotypes were determined using PCR
and restriction enzyme digestion. Chi-square test and simple logistic
regression yielding odds ratio (OR) was employed for comparison of
all parameters except for age of onset where t-test was used. Pa-
tients with GSTM1/GSTT1 polymorphism were associated with al-
most triple increased risk of mortality at 2-year after the ﬁrst
being diagnosed (OR 2.79, 95% CI 1.22–6.36). Mean age of onset













































































was higher in those with GSTT1 null (60.82 ± 10.61 years) and
GSTM1/GSTT1 polymorphism genotype (59.48 ± 11.30 years) com-
pared to lower mean age of onset for those with GSTT1 non-null
(58.15 ± 11.97 years) and GSTM1/GSTT1 wild-type genotype and
these observations were not signiﬁcant. There was also no signiﬁcant
difference between CYP1A1 and GSTM1 polymorphisms and age of
onset. Positive nodes are associated with high CYP1A1 polymor-
phism, GSTM1 null and GSTM1/GSTT1 polymorphism (59.7%, 56.5%
and 72.6%, respectively) and low GSTT1 null (29.0%). For tumor size
of more than 2 cm, there was higher percentage of GSTT1 null geno-
type (92.7%) as compared to those with tumor size of less than 2 cm
(p = 0.035). Polymorphisms of all three genes were higher in late
stage compared to early stage disease. However, statistically, these
observations were not signiﬁcant. In conclusion, no association
was observed between CYP1A1 and GSTM1 polymorphisms and all
clinicopathologic parameters studied. This study also showed that
for GSTM1/GSTT1 and GSTT1 polymorphisms, association was seen
with patients’ status at 2-year and tumor size respectively, indicat-
ing that the GST genotypes may be important indicators for the pa-
tients’ status and tumor size in oral cancer.
doi:10.1016/j.oos.2009.06.582
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The purpose of this study was to evaluate the clinical signiﬁcance
of VEGF-C and podoplanin expression in 42 well-differentiated oral
squamous cell carcinomas (OSCC), with and without lymph node
involvement, including eight verrucous carcinoma, treated at the
Department of the Head and Neck Surgery and Otorhinolaryngology,
AC. Camargo Cancer Hospital, São Paulo, from 1980 to 2000. Patients
were evaluated according the demographic, clinical and microscopic
parameters. In addition, we investigated the histopathological
malignancy index and the immunohistochemistry expression of
VEGF-C and podoplanin by malignant cells in the invasive front
tumor. Chi-square test or Fisher’s exact test was used to analyze
the association of VEGF-C and podoplanin with the variables above
in OSCC patients. The 5 and 10-year survival rates were calculated
by Kaplan–Meier method. Most of OSCC, including verrucous carci-
noma, showed a high expression of VEGF-C by malignant cells. The
OSCC patients with high expression of VEGF-C showed a tendency,
without statistical signiﬁcance, of local and/or regional recurrence.
The overexpression of podoplanin was signiﬁcantly associated with
the male gender (p = 0,037), with T1 and T2 stage (p = 0,037), with
I and II clinical stage (p = 0,027) and with the presence of glandular
inﬁltration (p = 0,003). The local and regional recurrences were de-
tected more frequently in OSCC with high expression of podoplanin,
without statistical signiﬁcant difference. The overall survival rates
and cancer speciﬁc survival rates for OSCC patients with high
VEGF-C expression and the overall survival rate for OSCC patients
with podoplanin overexpression were lower than those of OSCC pa-
tients with low expression of these proteins. The cervical lymph
node involvement was signiﬁcant prognostic factor (p = 0,001) for
patients with oral cancer. These results suggest that the overexpres-
sion of VEGF-C and podoplanin by malignant cells and regional
lymph node involvement are indicative factors of an unfavorable
clinical outcome and poor prognosis for patients OSCC.
doi:10.1016/j.oos.2009.06.583
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noma with positive neck metastasis
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Introduction: Lip carcinoma is one of the most common malig-
nant tumor in oral and maxillofacial region. In advanced stages with
regional metastasis it has a poor prognosis. E-cadherin and CD 44
molecules play a role in cell-to-cell adhesion; p53 is associated with
cellular proliferation and cell death.
Methods: To determine the expression of the E-cadherin, CD44,
and p53, and to establish their prognostic value and their clinical sig-
niﬁcance in the lip carcinoma. Immunohistochemical study of the E-
cadherin, CD44, and p53 proteins in 33 lip squamous cell carcinoma,
that were presented from the beginning with regional neck metasta-
sis or they presented positive lymph notes after the surgical inter-
vention of the primary lesion, over a period of 10 years. The data
obtained were subjected to uni- and multi-variate statistical analy-
ses. There were included only patients with a follow up over 5 years.
Results: Only 26 of the 33 cases with lip carcinoma provided en-
ough data to be evaluated. Immunostaining for CD44 was positive in
11 cases (42.31%), with more intense positivity in low histological
grade tumors. Positivity of E-cadherin was noticed in only one case
of the lip carcinomas (3.85%). In the 26 cases only 9 expressed the
p53 protein (34.62%). The expression of p53 was stronger in high his-
tological grade carcinomas and in tumors with high maximal
thickness.
Conclusions: Since all our patients had a poor prognosis, it seems
that decreased E-cadherin and CD 44 expression and over expression
of p53 in cancerous tissue correlates with this outcome in lip carci-
noma patients. Detection of the expression of these proteins is useful
to conﬁrm the risk for cervical lymph node metastasis; further stud-
ies are encouraged to reveal the detail mechanisms in formation of
lymph node metastatic focus.
doi:10.1016/j.oos.2009.06.584
P3.59. Signiﬁcant differences in p63,and Ki67 expression in oral
dysplasia from patients with or without oral squamous cell car-
cinoma: A retrospective longitudinal study
R. Czerninski a,*, M. Granit a, I. Kaplan b
aHebrew University, Hadassah School of Dental Medivcine, Israel
b Institute of Pathology, Rabin Medical Center and Sackler School of
Medicine, Tel-Aviv University, Israel
Background: Prediction of transformation of oral dysplastic le-
sions to carcinoma is currently impossible. Recent studies have
shown that clinical and microscopic ﬁndings in oral dysplasia and
oral squamous cell carcinoma (OSCC) are associated with a wide ar-
ray of changes in molecular markers including p63, p53, p16 (tumor
suppressor genes) and Ki67 (proliferation marker).
Aim: To compare p16, p63, p53 and Ki67 expression levels in oral
dysplastic lesions between patients with and without a history of
transformation to OSCC.
Methods: Sixty-ﬁve archival formalin ﬁxed, parafﬁn embedded
samples of dysplasia and OSCC from 30 patients with multiple oral
lesions were submitted for immunohistochemistry for ki67, p53,
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